FLGT - Fulgent Genetics names new chief medical officer

Fulgent Genetics ([[FLGT]] -4.0%) appoints of Lawrence Weiss, M.D. as Chief Medical Officer, reporting to the CEO, Ming Hsieh. Dr. Weiss will be responsible for expanding Fulgent’s reach in molecular diagnostics and driving the advancement of the Company’s portfolio of oncologic testing solutions.“Fulgent has a great opportunity to expand its presence in molecular diagnostics, and I am excited to join the team to help execute on the Company’s vision in this market. I believe that Fulgent has proven its ability to rapidly launch and scale new testing initiatives, and that my extensive background in pathology and molecular diagnostics will create a winning combination as we develop new testing solutions.” said Dr. Lawrence Weiss. Press Release

For further details see:

Fulgent Genetics names new chief medical officer